A cancer research fund at the Vrije Universiteit Brussel has reached the 1 miljoen euro milestone, as reported by BRUZZ. The donation was announced alongside Agnew’s upcoming performance titled ‘No More Heroes’, scheduled for October 8, 9, and 10 at the AFAS Dome in Antwerp, formerly known as the Sportpaleis. The funding also extends Agnew’s professorship at the Vrije Universiteit Brussel.
Researchers prepare clinical trial for personalized cancer treatment
Professor Damya Laoui leads the Vrije Universiteit Brussel research team tasked with finding a personalized cancer treatment. Investigators in her laboratory study dendritic cells, which are specialized immune system cells that recognize malignant cells and trigger other defense cells. The new financial support helps prepare for an initial clinical trial. Researchers aim to submit an application dossier to the Federal Agency for Medicines and Health Products by mid-2027. Following approval, a study involving lung cancer patients could begin later that year to test the treatment’s safety and feasibility.
Fund seeks more donations for clinical trial resources
Previous financial support from the professorship funded part of a 400,000-euro device needed to isolate studied dendritic cells from tumors. Yamina Krossa, who established the fund, described reaching the 1 miljoen euro mark as an important milestone. Organizers state that additional funding remains necessary because upcoming clinical trials require substantial resources. The fund now targets further donations with a goal of raising 1,2 miljoen euro.
Frequently Asked Questions About the Cancer Research Fund
When do researchers expect to submit their clinical trial application?
The research team aims to submit an application dossier to the Federal Agency for Medicines and Health Products by mid-2027.
How much money does the fund aim to raise next?
Having reached the 1 miljoen euro milestone, the fund now sets its next target at raising 1,2 miljoen euro to support upcoming clinical trials.